We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App





Thermo Fisher Collaborates with Artificial to Accelerate COVID-19 Diagnostics

By LabMedica International staff writers
Posted on 24 Mar 2021
Thermo Fisher Scientific Inc. More...
(Waltham, MA, USA) has entered into a strategic technology collaboration with Artificial, Inc. (Palo Alto, CA, USA) to develop an integrated and comprehensive software automation platform for Thermo Fisher's standardized COVID-19 Testing Platform.

As part of the collaboration, Artificial, developers of flexible automation software, will provide access to its aLab Suite software, designed to seamlessly integrate with Thermo Scientific Momentum Workflow software and robotics hardware. This will form part of the COVID-19 Testing Platform that will enable laboratories to quickly upscale COVID-19 testing volumes to help reduce the spread of the disease and restore economies and communities. The aLab Suite software facilitates the dynamic scheduling of protocol runs with batch optimizations to maximize the number of tests run. In addition, manual system set-up steps associated with Momentum process execution can be coordinated using aLab digital assistants to reduce the need for user input. Furthermore, the use of aLab assistant's digital twin of a COVID-19 testing system to guide lab technicians on where, when and how to load system consumables will reduce errors associated with manual tasks, ensuring sample safety and integrity and increasing system productivity. As part of the partnership, Thermo Fisher Scientific will utilize its extensive experience across life sciences to provide feedback on aLab Suite functionalities and capabilities to contribute to future product requirements and system specifications.

"Laboratories performing COVID-19 testing continue to face the combined challenges of rapidly scaling workflows to meet the demands of communities while ensuring the accuracy and reproducibility of results," said Hansjoerg Haas, senior director and general manager, laboratory automation, Thermo Fisher Scientific. "This collaboration enables biopharma and contract services companies to both simplify their lab technicians' interactions with automated systems and more efficiently coordinate the use of their multiple Momentum automated systems, increasing productivity and minimizing user intervention to meet industry needs."

"Artificial's aLab Suite is a great addition to Thermo Fisher's standardized COVID-19 Testing Platform solution in further enabling COVID-19 testing laboratories to easily and quickly scale their operations to meet the current demands," said David Fuller, CEO of Artificial. "Our partnership with Thermo Fisher Scientific represents an exciting opportunity to improve COVID-19 testing throughput and further develop the aLab Suite to address the pain points of the life sciences market."

Related Links:
Thermo Fisher Scientific Inc.
Artificial, Inc.



Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Collection and Transport System
PurSafe Plus®
New
Gold Member
Hematology Analyzer
Medonic M32B
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.